TrialPLoS medicine2021

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.

Houreratou Barry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.